Knowledge hub
News filter
Understanding the in-vitro/in-vivo relationship (IVIVR): inhaled medicinal products
In-vitro/in-vivo relationship (IVIVR) modeling leverages in-vitro testing knowledge in order to predict in-vivo results. This can often reduce long-term development costs and facilitate more informed decision making. Download this article to uncover how IVIVR works in practice and how Kindeva has demonstrated expertise in this area.
Read moreKindeva drug delivery – microneedles
Read moreKindeva Drug Delivery world vaccine congress presentation
Read moreThe History of therapeutic aerosols: A chronological review
Read moreAddressing the challenges of vaccines and intradermal delivery
Download this article for considerations of six shortcomings in vaccine development as it relates to intradermal delivery and thoughts on the industry can address these gaps: Where vaccines are delivered in the body Practical difficulties with intradermal delivery Delivery volume Scale-up Cold chain requirements Non-representative clinical trials
Read moreDevelopment of a theoretical model to predict pMDI spray force, using alternative propellant systems
Read moreApplication of theoretical models to predict expansion chamber pressure and temperature of HFA134a ethanol mixture during a pMDI actuation
Read moreManufacturing more tomorrows
Partner with us and benefit from a team with technical expertise and a passion for purpose. As a true partner, strategically minded and dedicated to your lasting legacy, we provide customized solutions tailored to your precise requirements. From development to commercial manufacturing and beyond, our CDMO solutions are designed to help your product progress with purpose.

Let’s transform tomorrow together
Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.